- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Secondary Progressive Multiple Sclerosis
Total 3323 results
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedSecondary Progressive Multiple SclerosisGermany
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
BiogenWithdrawn
-
University College London HospitalsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Novartis Pharmaceuticals; Autoimmunity Centers of ExcellenceCompletedSecondary Progressive Multiple SclerosisUnited States
-
Johns Hopkins UniversityHugo W. Moser Research Institute at Kennedy Krieger, Inc.CompletedSecondary Progressive Multiple SclerosisUnited States
-
University of CalgaryAlberta Innovates Health SolutionsCompletedMultiple Sclerosis, Secondary ProgressiveCanada
-
Imperial College LondonCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University of UtahMallinckrodtTerminatedOpen-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis (MSECP)Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkDanish Research Centre for Magnetic ResonanceUnknownMultiple Sclerosis (Primary or Secondary Progressive Phase).Denmark
-
University of ReginaUniversity of Saskatchewan; Saskatchewan Health Research Foundation; First Steps...RecruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveCanada
-
LAPIX Therapeutics Inc.CompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Leonardo A. Peyré-TartarugaAline Nogueira Haas; Flávia Gomes MartinezNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveBrazil
-
Cyprus University of TechnologyCyprus Institute of Neurology and GeneticsCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveCyprus
-
Daval International LimitedUnknownSecondary Progressive Multiple SclerosisUnited Kingdom
-
Stanford UniversityKyverna TherapeuticsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Emmanuelle Waubant, MD PhDUnited States Department of DefenseRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Institute of Psychiatry and Neurology, WarsawPoznan University of Medical Sciences; Nalecz Institute of Biocybernetics and... and other collaboratorsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary ProgressivePoland
-
University College, LondonNational Multiple Sclerosis SocietyCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Tiziana Life Sciences LTDRecruitingSecondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Bulgaria, Hungary, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, J... and more
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Opexa Therapeutics, Inc.CompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
Amsterdam UMC, location VUmcRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveNetherlands
-
Danish Research Centre for Magnetic ResonanceScleroseforeningen; Danish Multiple Sclerosis CenterCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveDenmark
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
BayerWithdrawnMultiple SclerosisSweden, Denmark
-
University of IowaDJO Incorporated; Direct MS Canada; Pinnaclife Inc.; TZ Press, LLCCompletedMultiple SclerosisUnited States
-
National Institute of Neurological Disorders and...Terminated
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
John F. Foley, MDGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis | Clinically Isolated Syndrome | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisGermany
-
National Center of Neurology and Psychiatry, JapanCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveJapan
-
University Hospital, CaenActive, not recruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisFrance
-
University of Alabama at BirminghamWashington University School of Medicine; United States Department of DefenseRecruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Shirley Ryan AbilityLabNorthwestern UniversityNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Abu Dhabi Stem Cells CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited Arab Emirates
-
SanofiRecruitingMultiple SclerosisKorea, Republic of, United States, China, Turkey, Canada, Australia, Puerto Rico, United Kingdom, Japan, Brazil
-
NovartisCompletedClinically Isolated Syndrome | Relapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse GraceCompletedHealthy | Clinically Isolated Syndrome | Multiple Sclerosis (MS) | Radiologically Isolated Syndrome | Multiple Sclerosis (MS) Relapsing Remitting | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary ProgressiveMonaco
-
Rennes University HospitalRecruiting
-
Novartis PharmaceuticalsAvailable
-
AB ScienceCompleted
-
Andalusian Initiative for Advanced Therapies -...Carlos III Health InstituteCompletedNervous System Diseases | Immune System Diseases | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Demyelinating Diseases | Autoimmune DiseasesSpain